Richard Nowak, MD, MS

Assistant Professor of Neurology; Director, Program in Clinical & Translational Neuromuscular Research ; Director, Yale Myasthenia Gravis Clinic

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Neurology: ALS/Myasthenia Gravis and Neuromuscular Disorders | Neurophysiology

Yale Medical Group

Clinical Trials

Conditions Study Title
ECU-MG-302: A Phase III, open-label, extension trial of ECU-MG-301 to evaluate the safety and efficacy of eculizumab in subjects with refractory generalized myasthenia gravis (gMG)
Neural, behavioral and physiological correlates of feeding in humans
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG)
International GBS Outcome Study
B Cell Targeted Treatment In Myasthenia Gravis: A Phase II Trial of Rituximab In Myasthenia Gravis
Neurology Blood Draw Protocol

Edit this profile

Contact Info

Richard Nowak, MD, MS
Patient Care Locations
Yale-New Haven Hospital
20 York Street

New Haven, CT 06510
Yale Neurosciences InstituteYale Physicians Building
800 Howard Avenue, Ste Lower Level

New Haven, CT 06519
Yale-New Haven Hospital Saint Raphael Campus
1450 Chapel Street

New Haven, CT 06511
Office Location
Yale School of Medicine, Department of Neurology Hunter Building
15 York Street, Ste 9th floor

New Haven, CT 06510
Mailing Address
PO Box 208018
New Haven, CT 06520-8082

Program in Clinical & Translational Neuromuscular Research (CTNR)